NCT03054922View on ClinicalTrials.gov

Impact of Intraoperative Fluid Management on Electrolyte and Acid-base Variables

PHASE3CompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

February 23, 2017

Primary Completion Date

September 30, 2018

Study Completion Date

September 30, 2018

Conditions
Anesthesia
Interventions
DRUG

Normal Saline

IV infusion of 0.9% NaCl throughout surgery.

DRUG

Lactated Ringer

IV infusion of lactated ringer throughout surgery.

DRUG

Normosol-R Inj

IV infusion of Normosol throughout surgery.

Trial Locations (1)

43205

Nationwide Children's Hospital, Columbus

All Listed Sponsors
lead

Nationwide Children's Hospital

OTHER

NCT03054922 - Impact of Intraoperative Fluid Management on Electrolyte and Acid-base Variables | Biotech Hunter | Biotech Hunter